With something as essential as breath, every moment matters.
Early detection saves lives. Let’s keep pushing for awareness and action.
#WorldLungCancerDay #EarlyDetection #LungCancerAwareness #CyPathLung
Early detection saves lives. Let’s keep pushing for awareness and action.
#WorldLungCancerDay #EarlyDetection #LungCancerAwareness #CyPathLung
August 1, 2025 at 7:47 PM
With something as essential as breath, every moment matters.
Early detection saves lives. Let’s keep pushing for awareness and action.
#WorldLungCancerDay #EarlyDetection #LungCancerAwareness #CyPathLung
Early detection saves lives. Let’s keep pushing for awareness and action.
#WorldLungCancerDay #EarlyDetection #LungCancerAwareness #CyPathLung
Congrats to this outstanding team for a great #ATS2026. #CyPathLung was well represented by your expertise, energy and teamwork.
#lungcancer #pulmonology #LungCancerAwareness #PulmonaryMedicine #HealthcareInnovation #Biotech #Diagnostics #Teamwork #ConferenceSuccess #ProudTeam
#lungcancer #pulmonology #LungCancerAwareness #PulmonaryMedicine #HealthcareInnovation #Biotech #Diagnostics #Teamwork #ConferenceSuccess #ProudTeam
May 20, 2026 at 6:16 PM
Congrats to this outstanding team for a great #ATS2026. #CyPathLung was well represented by your expertise, energy and teamwork.
#lungcancer #pulmonology #LungCancerAwareness #PulmonaryMedicine #HealthcareInnovation #Biotech #Diagnostics #Teamwork #ConferenceSuccess #ProudTeam
#lungcancer #pulmonology #LungCancerAwareness #PulmonaryMedicine #HealthcareInnovation #Biotech #Diagnostics #Teamwork #ConferenceSuccess #ProudTeam
A busy day at #ATS2026! Great conversations with pulmonologists, researchers & healthcare leaders about advancing early #lungcancer detection and the role of noninvasive diagnostics like #CyPathLung.
#EarlyDetection #Pulmonology #Innovation
#EarlyDetection #Pulmonology #Innovation
May 19, 2026 at 8:25 PM
A busy day at #ATS2026! Great conversations with pulmonologists, researchers & healthcare leaders about advancing early #lungcancer detection and the role of noninvasive diagnostics like #CyPathLung.
#EarlyDetection #Pulmonology #Innovation
#EarlyDetection #Pulmonology #Innovation
Introducing #CyPathLung, a noninvasive test that detects lung cancer at an early stage when it is most treatable and patients have a better outcome. To learn more about this test, visit our website at www.cypathlung.com
#lungcancer #screeningsaveslives #loveyourlungs #worldcancerday
#lungcancer #screeningsaveslives #loveyourlungs #worldcancerday
February 4, 2025 at 10:26 PM
Introducing #CyPathLung, a noninvasive test that detects lung cancer at an early stage when it is most treatable and patients have a better outcome. To learn more about this test, visit our website at www.cypathlung.com
#lungcancer #screeningsaveslives #loveyourlungs #worldcancerday
#lungcancer #screeningsaveslives #loveyourlungs #worldcancerday
92% sensitivity, 87% specificity in detecting lung cancer in high-risk patients with nodules <20mm.
Backed by data. Trusted by physicians.
Built for market growth.
Learn more: bit.ly/3I9i3mg
#CyPathLung #CancerDiagnostics #LungCancer #InvestorInsight
Backed by data. Trusted by physicians.
Built for market growth.
Learn more: bit.ly/3I9i3mg
#CyPathLung #CancerDiagnostics #LungCancer #InvestorInsight
July 3, 2025 at 6:43 PM
92% sensitivity, 87% specificity in detecting lung cancer in high-risk patients with nodules <20mm.
Backed by data. Trusted by physicians.
Built for market growth.
Learn more: bit.ly/3I9i3mg
#CyPathLung #CancerDiagnostics #LungCancer #InvestorInsight
Backed by data. Trusted by physicians.
Built for market growth.
Learn more: bit.ly/3I9i3mg
#CyPathLung #CancerDiagnostics #LungCancer #InvestorInsight
Only 12% of high-risk Texans receive recommended lung cancer screening — ranking Texas 46th nationally. Early detection and access matter.
Read the American Lung Association report at bit.ly/4qVmRwy
#lungcancer #EarlyDetection #HealthEquity #Diagnostics #PublicHealth #TexasHealthcare #CyPathLung
Read the American Lung Association report at bit.ly/4qVmRwy
#lungcancer #EarlyDetection #HealthEquity #Diagnostics #PublicHealth #TexasHealthcare #CyPathLung
January 15, 2026 at 6:31 PM
Only 12% of high-risk Texans receive recommended lung cancer screening — ranking Texas 46th nationally. Early detection and access matter.
Read the American Lung Association report at bit.ly/4qVmRwy
#lungcancer #EarlyDetection #HealthEquity #Diagnostics #PublicHealth #TexasHealthcare #CyPathLung
Read the American Lung Association report at bit.ly/4qVmRwy
#lungcancer #EarlyDetection #HealthEquity #Diagnostics #PublicHealth #TexasHealthcare #CyPathLung
Day 2 at #CHEST2025! Great conversations with clinicians & researchers advancing noninvasive lung diagnostics.
Our team at Booth 2242 is sharing how #CyPathLung uses flow cytometry + #AI to support earlier, more accurate detection of lung cancer.
#bioAffinityTechnologies #LungHealth #Diagnostics
Our team at Booth 2242 is sharing how #CyPathLung uses flow cytometry + #AI to support earlier, more accurate detection of lung cancer.
#bioAffinityTechnologies #LungHealth #Diagnostics
October 21, 2025 at 8:54 PM
Day 2 at #CHEST2025! Great conversations with clinicians & researchers advancing noninvasive lung diagnostics.
Our team at Booth 2242 is sharing how #CyPathLung uses flow cytometry + #AI to support earlier, more accurate detection of lung cancer.
#bioAffinityTechnologies #LungHealth #Diagnostics
Our team at Booth 2242 is sharing how #CyPathLung uses flow cytometry + #AI to support earlier, more accurate detection of lung cancer.
#bioAffinityTechnologies #LungHealth #Diagnostics
Great news for a program dear to our hearts: UT Health San Antonio's #lungcancer screening program. Congrats on the $30,000 gift from #NFL / #ACS #CrucialCatch for lung cancer screening in South Texas.
bit.ly/3ENgk4b
#UTSA #lungcancerscreening #CyPathLung
bit.ly/3ENgk4b
#UTSA #lungcancerscreening #CyPathLung
Mays Cancer Center continues collaboration with American Cancer Society to expand lung cancer screenings - UT Health San Antonio
Mays Cancer Center continues collaboration with American Cancer Society to expand lung cancer screenings
bit.ly
February 25, 2025 at 4:02 PM
Great news for a program dear to our hearts: UT Health San Antonio's #lungcancer screening program. Congrats on the $30,000 gift from #NFL / #ACS #CrucialCatch for lung cancer screening in South Texas.
bit.ly/3ENgk4b
#UTSA #lungcancerscreening #CyPathLung
bit.ly/3ENgk4b
#UTSA #lungcancerscreening #CyPathLung
“CyPath® Lung gave us the clarity we needed to act early,” said Dr. Gordon Downie, CMO, referring to a Stage 1A mucinous adenocarcinoma missed by other diagnostics.
Every early diagnosis is a life potentially saved.
Read the press release: bit.ly/4l6uOvn
#CyPathLung #LungCancer #bioAffinity
Every early diagnosis is a life potentially saved.
Read the press release: bit.ly/4l6uOvn
#CyPathLung #LungCancer #bioAffinity
July 29, 2025 at 9:50 PM
“CyPath® Lung gave us the clarity we needed to act early,” said Dr. Gordon Downie, CMO, referring to a Stage 1A mucinous adenocarcinoma missed by other diagnostics.
Every early diagnosis is a life potentially saved.
Read the press release: bit.ly/4l6uOvn
#CyPathLung #LungCancer #bioAffinity
Every early diagnosis is a life potentially saved.
Read the press release: bit.ly/4l6uOvn
#CyPathLung #LungCancer #bioAffinity
#WorldCancerDay
#CyPathLung and #bioAffinityTechnologies honor February 4 with a commitment to early detection of lung cancer. CyPath Lung is a noninvasive test ordered by your doctor if you are at risk for lung cancer.
#lungcancer #earlydiagnosissaveslives #screeningsaveslives
#CyPathLung and #bioAffinityTechnologies honor February 4 with a commitment to early detection of lung cancer. CyPath Lung is a noninvasive test ordered by your doctor if you are at risk for lung cancer.
#lungcancer #earlydiagnosissaveslives #screeningsaveslives
February 4, 2025 at 10:27 PM
#WorldCancerDay
#CyPathLung and #bioAffinityTechnologies honor February 4 with a commitment to early detection of lung cancer. CyPath Lung is a noninvasive test ordered by your doctor if you are at risk for lung cancer.
#lungcancer #earlydiagnosissaveslives #screeningsaveslives
#CyPathLung and #bioAffinityTechnologies honor February 4 with a commitment to early detection of lung cancer. CyPath Lung is a noninvasive test ordered by your doctor if you are at risk for lung cancer.
#lungcancer #earlydiagnosissaveslives #screeningsaveslives
@atscommunity.bsky.social annual conference this week, it is clear, CyPath® Lung offers significant benefits to physicians who are treating patients at high risk for lung cancer. If you're in San Francisco, stop by booth #2065 to learn more.
#AmericanThoracicSociety #CyPathLung #EarlyDetection
#AmericanThoracicSociety #CyPathLung #EarlyDetection
May 19, 2025 at 10:12 PM
@atscommunity.bsky.social annual conference this week, it is clear, CyPath® Lung offers significant benefits to physicians who are treating patients at high risk for lung cancer. If you're in San Francisco, stop by booth #2065 to learn more.
#AmericanThoracicSociety #CyPathLung #EarlyDetection
#AmericanThoracicSociety #CyPathLung #EarlyDetection
Canada awards patent for CyPath® Lung, expanding global protection of our noninvasive test for early lung cancer detection. With 92% sensitivity and 88% accuracy, early diagnosis can save lives. PR: bit.ly/CanadaPatent
#CyPathLung #LungCancer #Diagnostics #Biotech #Canada
#CyPathLung #LungCancer #Diagnostics #Biotech #Canada
Canada Awards New Patent to bioAffinity Technologies for CyPath® Lung, Company’s Noninvasive Lung Cancer Diagnostic - bioAffinity
New patent protects market expansion to the north where lung cancer is leading cause of cancer deaths SAN ANTONIO, TX — July 22, 2025 — bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechn...
bit.ly
July 22, 2025 at 5:53 PM
Canada awards patent for CyPath® Lung, expanding global protection of our noninvasive test for early lung cancer detection. With 92% sensitivity and 88% accuracy, early diagnosis can save lives. PR: bit.ly/CanadaPatent
#CyPathLung #LungCancer #Diagnostics #Biotech #Canada
#CyPathLung #LungCancer #Diagnostics #Biotech #Canada
👏A big congratulations to our outstanding team as they wrap up #AABIP2026!
Thank you for representing bioAffinity Technologies and #CyPathLung with professionalism, enthusiasm, and a commitment to advancing better approaches to lung cancer detection.
#LungCancer #LungCancerScreening #SalesTeam
Thank you for representing bioAffinity Technologies and #CyPathLung with professionalism, enthusiasm, and a commitment to advancing better approaches to lung cancer detection.
#LungCancer #LungCancerScreening #SalesTeam
August 22, 2026 at 2:44 PM
👏A big congratulations to our outstanding team as they wrap up #AABIP2026!
Thank you for representing bioAffinity Technologies and #CyPathLung with professionalism, enthusiasm, and a commitment to advancing better approaches to lung cancer detection.
#LungCancer #LungCancerScreening #SalesTeam
Thank you for representing bioAffinity Technologies and #CyPathLung with professionalism, enthusiasm, and a commitment to advancing better approaches to lung cancer detection.
#LungCancer #LungCancerScreening #SalesTeam
We're looking forward to this upcoming webinar because staying on top of #lungcancer policy is one way to advance better outcomes for patients.
📅 Aug 19 ⏰ 12-1pm ET
🔗 Register: brnw.ch/21x4OUg
#LungCancerAdvocacy #LungCancerCommunity #PatientAdvocacy #CyPathLung
📅 Aug 19 ⏰ 12-1pm ET
🔗 Register: brnw.ch/21x4OUg
#LungCancerAdvocacy #LungCancerCommunity #PatientAdvocacy #CyPathLung
August 14, 2026 at 6:15 PM
We're looking forward to this upcoming webinar because staying on top of #lungcancer policy is one way to advance better outcomes for patients.
📅 Aug 19 ⏰ 12-1pm ET
🔗 Register: brnw.ch/21x4OUg
#LungCancerAdvocacy #LungCancerCommunity #PatientAdvocacy #CyPathLung
📅 Aug 19 ⏰ 12-1pm ET
🔗 Register: brnw.ch/21x4OUg
#LungCancerAdvocacy #LungCancerCommunity #PatientAdvocacy #CyPathLung
Proud to be a member of the American Lung Association's Health Industry Council Members, working together to save lives. Sharing ALA's video tribute to its industry partners and our impact in 2026. lnkd.in/gf3m7xBN
#lungcancer #lunghealth #CyPathLung #patientadvocacy
#lungcancer #lunghealth #CyPathLung #patientadvocacy
August 12, 2026 at 5:39 PM
Proud to be a member of the American Lung Association's Health Industry Council Members, working together to save lives. Sharing ALA's video tribute to its industry partners and our impact in 2026. lnkd.in/gf3m7xBN
#lungcancer #lunghealth #CyPathLung #patientadvocacy
#lungcancer #lunghealth #CyPathLung #patientadvocacy
transformations with fine-grained local corrections to achieve robust tissue patch alignment. We evaluate UWarp using two private datasets, CypathLung and BosomShieldBreast, containing whole slide images scanned by multiple devices. Our experiments [4/7 of https://arxiv.org/abs/2503.20653v1]
March 27, 2025 at 6:03 AM
transformations with fine-grained local corrections to achieve robust tissue patch alignment. We evaluate UWarp using two private datasets, CypathLung and BosomShieldBreast, containing whole slide images scanned by multiple devices. Our experiments [4/7 of https://arxiv.org/abs/2503.20653v1]
Thx to @LungAssociation for recent blog bit.ly/3Sw03aP to dispel common #lungcancer myths & reinforce the importance of early detection. #CyPathLung is a noninvasive tool that helps physicians assess lung cancer risk. #EarlyDetection #PulmonaryNodules #LungHealth #AmericanLungAssociation
June 25, 2026 at 10:41 PM
Thx to @LungAssociation for recent blog bit.ly/3Sw03aP to dispel common #lungcancer myths & reinforce the importance of early detection. #CyPathLung is a noninvasive tool that helps physicians assess lung cancer risk. #EarlyDetection #PulmonaryNodules #LungHealth #AmericanLungAssociation
A new study found smoking-duration criterion performed similarly to current U.S. screening guidelines. bit.ly/4akCjwq
Tools like CyPath® Lung can help physicians assess high-risk after screening.
#LungCancer #LungCancerScreening #CyPathLung #EarlyDetection
Tools like CyPath® Lung can help physicians assess high-risk after screening.
#LungCancer #LungCancerScreening #CyPathLung #EarlyDetection
June 24, 2026 at 2:23 PM
A new study found smoking-duration criterion performed similarly to current U.S. screening guidelines. bit.ly/4akCjwq
Tools like CyPath® Lung can help physicians assess high-risk after screening.
#LungCancer #LungCancerScreening #CyPathLung #EarlyDetection
Tools like CyPath® Lung can help physicians assess high-risk after screening.
#LungCancer #LungCancerScreening #CyPathLung #EarlyDetection
🫁 Missed the SAB-hosted webinar on changes in lung nodule management? The recording is now available! Experts unpack how CyPath® Lung is transforming lung nodule care. Watch now👉https://bit.ly/43N4fW1
#cypathlung #lungcancer #SAB
#cypathlung #lungcancer #SAB
June 19, 2026 at 8:38 PM
🫁 Missed the SAB-hosted webinar on changes in lung nodule management? The recording is now available! Experts unpack how CyPath® Lung is transforming lung nodule care. Watch now👉https://bit.ly/43N4fW1
#cypathlung #lungcancer #SAB
#cypathlung #lungcancer #SAB
Webinar on #CyPathLung expanding role in #pulmonary, #oncology and surgical practices for the detection and management of early-stage #lungcancer.
June 16, 2026 at 7 p.m. ET
Hosted by Society for Advanced Bronchoscopy (SAB)
Register at bit.ly/3PaFPSR
#LungNodules #Bronchoscopy #EarlyDetection
June 16, 2026 at 7 p.m. ET
Hosted by Society for Advanced Bronchoscopy (SAB)
Register at bit.ly/3PaFPSR
#LungNodules #Bronchoscopy #EarlyDetection
June 5, 2026 at 8:21 PM
Webinar on #CyPathLung expanding role in #pulmonary, #oncology and surgical practices for the detection and management of early-stage #lungcancer.
June 16, 2026 at 7 p.m. ET
Hosted by Society for Advanced Bronchoscopy (SAB)
Register at bit.ly/3PaFPSR
#LungNodules #Bronchoscopy #EarlyDetection
June 16, 2026 at 7 p.m. ET
Hosted by Society for Advanced Bronchoscopy (SAB)
Register at bit.ly/3PaFPSR
#LungNodules #Bronchoscopy #EarlyDetection
bioAffinity Technologies
@bioAffinity
Only about 1 in 4 eligible Americans were up to date with #lungcancerscreening in 2024, according to a research letter posted on #JAMA.
Early detection matters. #CyPathLung can make a difference.
#LungCancerAwareness #EarlyDetection #LungHealth #Pulmonology
@bioAffinity
Only about 1 in 4 eligible Americans were up to date with #lungcancerscreening in 2024, according to a research letter posted on #JAMA.
Early detection matters. #CyPathLung can make a difference.
#LungCancerAwareness #EarlyDetection #LungHealth #Pulmonology
May 22, 2026 at 9:26 PM
bioAffinity Technologies
@bioAffinity
Only about 1 in 4 eligible Americans were up to date with #lungcancerscreening in 2024, according to a research letter posted on #JAMA.
Early detection matters. #CyPathLung can make a difference.
#LungCancerAwareness #EarlyDetection #LungHealth #Pulmonology
@bioAffinity
Only about 1 in 4 eligible Americans were up to date with #lungcancerscreening in 2024, according to a research letter posted on #JAMA.
Early detection matters. #CyPathLung can make a difference.
#LungCancerAwareness #EarlyDetection #LungHealth #Pulmonology
bioAffinity Technologies appreciates the opportunity to collaborate with the American Lung Association to advance lung health initiatives as a member of the ALA Health Industry Council.
#AmericanLungAssociation #lunghealth #ATS2026 #CyPathLung #lungcancer #biotech
#AmericanLungAssociation #lunghealth #ATS2026 #CyPathLung #lungcancer #biotech
May 20, 2026 at 7:27 PM
bioAffinity Technologies appreciates the opportunity to collaborate with the American Lung Association to advance lung health initiatives as a member of the ALA Health Industry Council.
#AmericanLungAssociation #lunghealth #ATS2026 #CyPathLung #lungcancer #biotech
#AmericanLungAssociation #lunghealth #ATS2026 #CyPathLung #lungcancer #biotech
CyPath® Lung, our noninvasive, AI-powered diagnostic test with at-home sample collection, is helping advance earlier lung cancer risk assessment and support clinical decision-making.
#ATS2026 #LungCancer #EarlyDetection #Pulmonology #Innovation #CyPathLung
#ATS2026 #LungCancer #EarlyDetection #Pulmonology #Innovation #CyPathLung
May 19, 2026 at 1:51 PM
CyPath® Lung, our noninvasive, AI-powered diagnostic test with at-home sample collection, is helping advance earlier lung cancer risk assessment and support clinical decision-making.
#ATS2026 #LungCancer #EarlyDetection #Pulmonology #Innovation #CyPathLung
#ATS2026 #LungCancer #EarlyDetection #Pulmonology #Innovation #CyPathLung
🫁 Join Society for Advanced Bronchoscopy June 16, 7 PM ET for webinar on managing pulmonary nodules with noninvasive CyPath® Lung testing. Register now at bit.ly/3PaFPSR
#LungCancer #PulmonaryNodules #EarlyDetection #Pulmonology #ThoracicSurgery #Oncology #PrecisionMedicine #CyPathLung
#LungCancer #PulmonaryNodules #EarlyDetection #Pulmonology #ThoracicSurgery #Oncology #PrecisionMedicine #CyPathLung
May 18, 2026 at 3:54 PM
🫁 Join Society for Advanced Bronchoscopy June 16, 7 PM ET for webinar on managing pulmonary nodules with noninvasive CyPath® Lung testing. Register now at bit.ly/3PaFPSR
#LungCancer #PulmonaryNodules #EarlyDetection #Pulmonology #ThoracicSurgery #Oncology #PrecisionMedicine #CyPathLung
#LungCancer #PulmonaryNodules #EarlyDetection #Pulmonology #ThoracicSurgery #Oncology #PrecisionMedicine #CyPathLung
CyPath® Lung:
· Noninvasive
· Real-time results
· Potential healthcare savings
#ATS2026 #CyPathLung #lungcancer #pulmonology #flowcytometry
· Noninvasive
· Real-time results
· Potential healthcare savings
#ATS2026 #CyPathLung #lungcancer #pulmonology #flowcytometry
May 15, 2026 at 9:14 PM
CyPath® Lung:
· Noninvasive
· Real-time results
· Potential healthcare savings
#ATS2026 #CyPathLung #lungcancer #pulmonology #flowcytometry
· Noninvasive
· Real-time results
· Potential healthcare savings
#ATS2026 #CyPathLung #lungcancer #pulmonology #flowcytometry